var data={"name":"Pediatric immunology","type":"SECTION","numTopics":"11,000","numSpecialties":"over 22","sections":[{"name":"Antibody deficiencies","type":"SUBSECTION","items":[{"name":"Agammaglobulinemia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=agammaglobulinemia"},{"name":"Clinical manifestations, epidemiology, and diagnosis of common variable immunodeficiency in adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-manifestations-epidemiology-and-diagnosis-of-common-variable-immunodeficiency-in-adults"},{"name":"IgG subclass deficiency","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=igg-subclass-deficiency"},{"name":"IgG subclasses: Physical properties, genetics, and biologic functions","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=igg-subclasses-physical-properties-genetics-and-biologic-functions"},{"name":"Pathogenesis of common variable immunodeficiency","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pathogenesis-of-common-variable-immunodeficiency"},{"name":"Selective IgA deficiency: Clinical manifestations, pathophysiology, and diagnosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=selective-iga-deficiency-clinical-manifestations-pathophysiology-and-diagnosis"},{"name":"Selective IgM deficiency","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=selective-igm-deficiency"},{"name":"Specific antibody deficiency","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=specific-antibody-deficiency"},{"name":"Transient hypogammaglobulinemia of infancy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=transient-hypogammaglobulinemia-of-infancy"}]},{"name":"Cellular immunity","type":"SUBSECTION","items":[{"name":"Antigen-presenting cells","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=antigen-presenting-cells"},{"name":"Apoptosis and autoimmune disease","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=apoptosis-and-autoimmune-disease"},{"name":"Immunology of the maternal-fetal interface","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=immunology-of-the-maternal-fetal-interface"},{"name":"Mast cells: Development, identification, and physiologic roles","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=mast-cells-development-identification-and-physiologic-roles"},{"name":"T cell receptor genetics","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=t-cell-receptor-genetics"},{"name":"T helper subsets: Differentiation and role in disease","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=t-helper-subsets-differentiation-and-role-in-disease"},{"name":"The adaptive cellular immune response","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=the-adaptive-cellular-immune-response"},{"name":"Toll-like receptors: Roles in disease and therapy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=toll-like-receptors-roles-in-disease-and-therapy"}]},{"name":"Chromosomal breakage syndromes associated with immunodeficiency","type":"SUBSECTION","items":[{"name":"Bloom syndrome","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=bloom-syndrome"},{"name":"Nijmegen breakage syndrome","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=nijmegen-breakage-syndrome"}]},{"name":"Combined immunodeficiency","type":"SUBSECTION","items":[{"name":"Adenosine deaminase deficiency: Pathogenesis, clinical manifestations, and diagnosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=adenosine-deaminase-deficiency-pathogenesis-clinical-manifestations-and-diagnosis"},{"name":"Adenosine deaminase deficiency: Treatment","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=adenosine-deaminase-deficiency-treatment"},{"name":"Combined immunodeficiencies","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=combined-immunodeficiencies"},{"name":"Immunizations in patients with primary immunodeficiency","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=immunizations-in-patients-with-primary-immunodeficiency"},{"name":"Primary immunodeficiency: Overview of management","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=primary-immunodeficiency-overview-of-management"},{"name":"Purine nucleoside phosphorylase deficiency","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=purine-nucleoside-phosphorylase-deficiency"},{"name":"Severe combined immunodeficiency (SCID) with JAK3 deficiency","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=severe-combined-immunodeficiency-scid-with-jak3-deficiency"},{"name":"Severe combined immunodeficiency (SCID): An overview","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=severe-combined-immunodeficiency-scid-an-overview"},{"name":"Severe combined immunodeficiency (SCID): Specific defects","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=severe-combined-immunodeficiency-scid-specific-defects"},{"name":"T cell receptor signaling","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=t-cell-receptor-signaling"},{"name":"T-B-NK+ SCID: Clinical manifestations, diagnosis, and treatment","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=t-b-nk-scid-clinical-manifestations-diagnosis-and-treatment"},{"name":"T-B-NK+ SCID: Pathogenesis and genetics","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=t-b-nk-scid-pathogenesis-and-genetics"},{"name":"X-linked severe combined immunodeficiency (SCID)","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=x-linked-severe-combined-immunodeficiency-scid"},{"name":"ZAP-70 deficiency","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=zap-70-deficiency"}]},{"name":"Cytokines and inflammation","type":"SUBSECTION","items":[{"name":"Acute phase reactants","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=acute-phase-reactants"},{"name":"Overview of autoimmunity","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-autoimmunity"},{"name":"Role of cytokines in the immune system","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=role-of-cytokines-in-the-immune-system"}]},{"name":"HLA","type":"SUBSECTION","items":[{"name":"Human leukocyte antigens (HLA): A roadmap","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=human-leukocyte-antigens-hla-a-roadmap"},{"name":"Major histocompatibility complex (MHC) structure and function","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=major-histocompatibility-complex-mhc-structure-and-function"}]},{"name":"Humoral immunity","type":"SUBSECTION","items":[{"name":"Agammaglobulinemia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=agammaglobulinemia"},{"name":"Immunity of the newborn","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=immunity-of-the-newborn"},{"name":"Immunoglobulin genetics","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=immunoglobulin-genetics"},{"name":"Overview of therapeutic monoclonal antibodies","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-therapeutic-monoclonal-antibodies"},{"name":"Primary humoral immunodeficiencies: An overview","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=primary-humoral-immunodeficiencies-an-overview"},{"name":"Structure of immunoglobulins","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=structure-of-immunoglobulins"},{"name":"The humoral immune response","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=the-humoral-immune-response"}]},{"name":"Immunodeficiency disorders - General considerations","type":"SUBSECTION","items":[{"name":"Flow cytometry for the diagnosis of primary immunodeficiencies","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=flow-cytometry-for-the-diagnosis-of-primary-immunodeficiencies"},{"name":"Immune globulin therapy in primary immunodeficiency","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=immune-globulin-therapy-in-primary-immunodeficiency"},{"name":"Laboratory evaluation of the immune system","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=laboratory-evaluation-of-the-immune-system"}]},{"name":"Infection issues in the compromised host","type":"SUBSECTION","items":[{"name":"Approach to the child with recurrent infections","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=approach-to-the-child-with-recurrent-infections"}]},{"name":"Other","type":"SUBSECTION","items":[{"name":"Hyperimmunoglobulin D syndrome: Clinical manifestations and diagnosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=hyperimmunoglobulin-d-syndrome-clinical-manifestations-and-diagnosis"},{"name":"Hyperimmunoglobulin D syndrome: Management","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=hyperimmunoglobulin-d-syndrome-management"},{"name":"Hyperimmunoglobulin D syndrome: Pathophysiology","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=hyperimmunoglobulin-d-syndrome-pathophysiology"},{"name":"Periodic fever syndromes and other autoinflammatory diseases: An overview","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=periodic-fever-syndromes-and-other-autoinflammatory-diseases-an-overview"},{"name":"Periodic fever with aphthous stomatitis, pharyngitis, and adenitis (PFAPA syndrome)","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=periodic-fever-with-aphthous-stomatitis-pharyngitis-and-adenitis-pfapa-syndrome"},{"name":"Tumor necrosis factor receptor-1 associated periodic syndrome (TRAPS)","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=tumor-necrosis-factor-receptor-1-associated-periodic-syndrome-traps"}]},{"name":"Other well defined immunodeficiency syndromes","type":"SUBSECTION","items":[{"name":"Autosomal dominant hyperimmunoglobulin E syndrome","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=autosomal-dominant-hyperimmunoglobulin-e-syndrome"},{"name":"Cartilage-hair hypoplasia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=cartilage-hair-hypoplasia"},{"name":"DiGeorge (22q11.2 deletion) syndrome: Clinical features and diagnosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=digeorge-22q11-2-deletion-syndrome-clinical-features-and-diagnosis"},{"name":"DiGeorge (22q11.2 deletion) syndrome: Epidemiology and pathogenesis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=digeorge-22q11-2-deletion-syndrome-epidemiology-and-pathogenesis"},{"name":"DiGeorge (22q11.2 deletion) syndrome: Management and prognosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=digeorge-22q11-2-deletion-syndrome-management-and-prognosis"},{"name":"IPEX: Immune dysregulation, polyendocrinopathy, enteropathy, X-linked","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=ipex-immune-dysregulation-polyendocrinopathy-enteropathy-x-linked"},{"name":"Mannose-binding lectin","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=mannose-binding-lectin"},{"name":"Mannose-binding lectin deficiency","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=mannose-binding-lectin-deficiency"},{"name":"Mendelian susceptibility to mycobacterial diseases: An overview","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=mendelian-susceptibility-to-mycobacterial-diseases-an-overview"},{"name":"Mendelian susceptibility to mycobacterial diseases: Specific defects","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=mendelian-susceptibility-to-mycobacterial-diseases-specific-defects"},{"name":"NK cell deficiency syndromes: Clinical manifestations and diagnosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=nk-cell-deficiency-syndromes-clinical-manifestations-and-diagnosis"},{"name":"NK cell deficiency syndromes: Treatment","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=nk-cell-deficiency-syndromes-treatment"},{"name":"Wiskott-Aldrich syndrome","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=wiskott-aldrich-syndrome"},{"name":"X-linked lymphoproliferative disease","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=x-linked-lymphoproliferative-disease"}]},{"name":"Phagocyte disorders","type":"SUBSECTION","items":[{"name":"Chediak-Higashi syndrome","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=chediak-higashi-syndrome"},{"name":"Chronic granulomatous disease: Pathogenesis, clinical manifestations, and diagnosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=chronic-granulomatous-disease-pathogenesis-clinical-manifestations-and-diagnosis"},{"name":"Chronic granulomatous disease: Treatment and prognosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=chronic-granulomatous-disease-treatment-and-prognosis"},{"name":"Inherited disorders of the complement system","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=inherited-disorders-of-the-complement-system"},{"name":"Leukocyte-adhesion deficiency","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=leukocyte-adhesion-deficiency"},{"name":"Myeloperoxidase deficiency and other enzymatic WBC defects causing immunodeficiency","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=myeloperoxidase-deficiency-and-other-enzymatic-wbc-defects-causing-immunodeficiency"},{"name":"Neutrophil-specific granule deficiency","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=neutrophil-specific-granule-deficiency"},{"name":"Overview and clinical assessment of the complement system","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-and-clinical-assessment-of-the-complement-system"},{"name":"Primary disorders of phagocytic function: An overview","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=primary-disorders-of-phagocytic-function-an-overview"}]},{"name":"Secondary immune deficiency","type":"SUBSECTION","items":[{"name":"Secondary immunodeficiency due to underlying disease states, environmental exposures, and miscellaneous causes","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=secondary-immunodeficiency-due-to-underlying-disease-states-environmental-exposures-and-miscellaneous-causes"}]},{"name":"Secondary immunodeficiency","type":"SUBSECTION","items":[{"name":"CD3/T cell receptor complex disorders causing immunodeficiency","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=cd3-t-cell-receptor-complex-disorders-causing-immunodeficiency"},{"name":"Syndromic immunodeficiencies","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=syndromic-immunodeficiencies"}]},{"name":"Transplantation immunology","type":"SUBSECTION","items":[{"name":"Gene therapy for primary immunodeficiency","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=gene-therapy-for-primary-immunodeficiency"},{"name":"Hematopoietic cell transplantation for primary immunodeficiency","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=hematopoietic-cell-transplantation-for-primary-immunodeficiency"},{"name":"Pathogenesis of graft-versus-host disease","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pathogenesis-of-graft-versus-host-disease"},{"name":"Transplantation immunobiology","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=transplantation-immunobiology"}]}]}